| RS2135916511 |
PTPN11
|
Health Risk |
Pathogenic |
RASopathy, RASopathy |
| RS2135916870 |
KIF11
|
Health Risk |
Pathogenic |
— |
| RS2135916921 |
KIF11
|
Health Risk |
Pathogenic |
— |
| RS2135917031 |
PC
|
Health Risk |
Pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS2135917229 |
PC
|
Health Risk |
Pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS2135917390 |
ATP6V0A2
|
Health Risk |
Conflicting classifications of pathogenicity |
ALG9 congenital disorder of glycosylation, Inborn genetic diseases |
| RS2135917452 |
PC
|
Health Risk |
Pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS2135917561 |
PC
|
Health Risk |
Pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS2135918018 |
LRP6
|
Health Risk |
Pathogenic |
Tooth agenesis, selective |
| RS2135919112 |
KIF11
|
Health Risk |
Pathogenic |
— |
| RS2135919274 |
KIF11
|
Health Risk |
Pathogenic |
— |
| RS2135920313 |
EXPH5
|
Health Risk |
Pathogenic |
Epidermolysis bullosa simplex 4, localized or generalized intermediate |
| RS2135920462 |
KIF11
|
Health Risk |
Likely pathogenic |
— |
| RS2135920743 |
ATP6V0A2
|
Health Risk |
Pathogenic |
ALG9 congenital disorder of glycosylation, ALG9 congenital disorder of glycosylation |
| RS2135921186 |
STT3A
|
Health Risk |
Likely pathogenic |
Congenital disorder of glycosylation, type Iw |
| RS2135923352 |
KIF11
|
Health Risk |
Pathogenic |
Microcephaly with or without chorioretinopathy, lymphedema |
| RS2135923385 |
KIF11
|
Health Risk |
Pathogenic |
— |
| RS2135923421 |
KIF11
|
Health Risk |
Pathogenic |
Microcephaly with or without chorioretinopathy, lymphedema |
| RS2135923456 |
KIF11
|
Health Risk |
Pathogenic |
— |
| RS2135923459 |
KIF11
|
Health Risk |
Pathogenic |
Microcephaly with or without chorioretinopathy, lymphedema |
| RS2135923477 |
KIF11
|
Health Risk |
Pathogenic |
Microcephaly with or without chorioretinopathy, lymphedema |
| RS2135923500 |
KIF11
|
Health Risk |
Pathogenic |
— |
| RS2135924347 |
EXPH5
|
Health Risk |
Pathogenic |
Epidermolysis bullosa simplex 4, localized or generalized intermediate |
| RS2135924889 |
KIF11
|
Health Risk |
Pathogenic |
— |
| RS2135925063 |
FLI1
|
Health Risk |
Likely pathogenic |
Bleeding disorder, platelet-type |
| RS2135925601 |
KIF11
|
Health Risk |
Pathogenic |
Microcephaly with or without chorioretinopathy, lymphedema |
| RS2135925610 |
KIF11
|
Health Risk |
Pathogenic |
— |
| RS2135925949 |
KIF11
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS2135926480 |
DHX37
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with brain anomalies and with or without vertebral or cardiac anomalies, Neurodevelopmental disorder with brain anomalies and with or without vertebral or cardiac anomalies |
| RS2135926774 |
ATM
|
Health Risk |
Likely pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2135927478 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2135927504 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2135927905 |
EXPH5
|
Health Risk |
Pathogenic |
Epidermolysis bullosa simplex 4, localized or generalized intermediate |
| RS2135927977 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2135928197 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS2135928495 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2135928801 |
PTPN11
|
Health Risk |
Conflicting classifications of pathogenicity |
Noonan syndrome and Noonan-related syndrome, Cardiovascular phenotype |
| RS2135928904 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2135929688 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2135930082 |
SUFU
|
Health Risk |
Pathogenic |
Medulloblastoma, Gorlin syndrome |
| RS2135930329 |
SUFU
|
Health Risk |
Pathogenic |
Gorlin syndrome, Medulloblastoma |
| RS2135936249 |
PHF21A
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with behavioral abnormalities and craniofacial dysmorphism with or without seizures, Intellectual developmental disorder with behavioral abnormalities and craniofacial dysmorphism with or without seizures |
| RS2135938300 |
STT3A
|
Health Risk |
Likely pathogenic |
Congenital disorder of glycosylation, type Iw |
| RS2135939447 |
DHCR7
|
Health Risk |
Likely pathogenic |
Smith-Lemli-Opitz syndrome, Smith-Lemli-Opitz syndrome |
| RS2135939478 |
DHCR7
|
Health Risk |
Pathogenic |
Smith-Lemli-Opitz syndrome, Smith-Lemli-Opitz syndrome |
| RS2135939533 |
DHCR7
|
Health Risk |
Likely pathogenic |
Smith-Lemli-Opitz syndrome, Smith-Lemli-Opitz syndrome |
| RS2135940013 |
DHCR7
|
Health Risk |
Pathogenic |
Smith-Lemli-Opitz syndrome, Smith-Lemli-Opitz syndrome |
| RS2135940147 |
DHCR7
|
Health Risk |
Pathogenic |
Smith-Lemli-Opitz syndrome, Smith-Lemli-Opitz syndrome |
| RS2135940752 |
PC
|
Health Risk |
Pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS2135940951 |
PC
|
Health Risk |
Likely pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS2135941091 |
KCNJ1
|
Health Risk |
Pathogenic |
Bartter disease type 2, Bartter disease type 2 |
| RS2135941775 |
DHCR7
|
Health Risk |
Pathogenic |
Smith-Lemli-Opitz syndrome, Smith-Lemli-Opitz syndrome |
| RS2135941811 |
DHCR7
|
Health Risk |
Pathogenic |
Smith-Lemli-Opitz syndrome, Smith-Lemli-Opitz syndrome |
| RS2135941937 |
PC
|
Health Risk |
Pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS2135942244 |
ATP2B1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental delay, Clubfoot |
| RS2135942891 |
DHCR7
|
Health Risk |
Pathogenic |
Smith-Lemli-Opitz syndrome, Smith-Lemli-Opitz syndrome |
| RS2135943149 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2135943275 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2135944016 |
ATM
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2135944112 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2135944550 |
DHCR7
|
Health Risk |
Pathogenic |
Smith-Lemli-Opitz syndrome, Smith-Lemli-Opitz syndrome |
| RS2135944619 |
DHCR7
|
Health Risk |
Likely pathogenic |
Smith-Lemli-Opitz syndrome, Smith-Lemli-Opitz syndrome |
| RS2135944782 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2135945152 |
DHX37
|
Health Risk |
Likely pathogenic |
46, XY sex reversal 11 |
| RS2135945513 |
DHCR7
|
Health Risk |
Likely pathogenic |
Smith-Lemli-Opitz syndrome, Smith-Lemli-Opitz syndrome |
| RS2135945639 |
DHCR7
|
Health Risk |
Conflicting classifications of pathogenicity |
Smith-Lemli-Opitz syndrome, Smith-Lemli-Opitz syndrome |
| RS2135946188 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2135946371 |
PAN2
|
Health Risk |
Pathogenic/Likely pathogenic |
PAN2-related multiple congenital anomalies syndrome, DEVELOPMENTAL DELAY WITH VARIABLE CARDIAC AND RENAL CONGENITAL ANOMALIES AND DYSMORPHIC FACIES |
| RS2135946592 |
ATM
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2135947041 |
PCDH15
|
Health Risk |
Likely pathogenic |
— |
| RS2135947078 |
PCDH15
|
Health Risk |
Pathogenic |
— |
| RS2135947998 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2135948486 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2135949218 |
POLE
|
Health Risk |
Likely pathogenic |
Colorectal cancer, susceptibility to |
| RS2135949491 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2135949570 |
ATP2B1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2135954200 |
SUFU
|
Health Risk |
Pathogenic/Likely pathogenic |
Gorlin syndrome, Medulloblastoma |
| RS2135956665 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2135957798 |
PFKM
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type VII |
| RS2135958616 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2135958617 |
POLE
|
Health Risk |
Likely pathogenic |
— |
| RS2135959437 |
SUFU
|
Health Risk |
Likely pathogenic |
Familial meningioma, Familial meningioma |
| RS2135961598 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2135962410 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2135963070 |
RAP1B
|
Health Risk |
Likely pathogenic |
See cases, Thrombocytopenia 11 with multiple congenital anomalies and dysmorphic facies |
| RS2135969134 |
POLE
|
Health Risk |
Likely pathogenic |
— |
| RS2135969239 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2135969291 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2135971223 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2135975361 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2135975397 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2135975662 |
ATM
|
Health Risk |
Likely pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2135975673 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2135975734 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2135976459 |
PFKM
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type VII |
| RS2135976472 |
POLE
|
Health Risk |
Likely pathogenic |
— |
| RS2135976833 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2135976898 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2135977126 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2135977494 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |